订阅
加入社区
订阅邮件,第一时间获取最新资讯与更新
Clinically validated autism spectrum screening platform offering RAADS-R, AQ, and CAT-Q assessments with HIPAA-compliant privacy protection.
MindSpectrum is a web-based mental health platform that gives adults access to three clinically validated autism screening instruments — RAADS-R, AQ, and CAT-Q — without a referral, a waitlist, or a clinical appointment. The core outcome is self-understanding: users complete one or more assessments, receive a detailed score report, and leave with documented evidence of their trait profile that they can bring into a conversation with a clinician.
The platform hosts three tools that are widely used in research and clinical settings. The RAADS-R (Ritvo Autism Asperger Diagnostic Scale–Revised) covers 80 items across four domains and is cited in over 500 peer-reviewed publications. The Autism-Spectrum Quotient (AQ), developed at Cambridge University's Autism Research Centre, spans 50 questions and has been validated across more than 3,000 studies. The CAT-Q (Camouflaging Autistic Traits Questionnaire) focuses specifically on social masking and camouflaging behaviors — a dimension that standard screenings often miss, particularly for women and gender-diverse individuals.
Each assessment generates a downloadable report with domain-level score breakdowns and references to the underlying research. The reports are structured to be useful at clinical appointments, not just for personal reflection.
MindSpectrum is designed for adults aged 16 and older. The most common users are people who have spent years feeling socially or sensorially different without a clear explanation, and who want to explore whether autism might account for those experiences before committing to a formal — and often expensive — diagnostic process.
It also serves a few more specific groups. Late-identified adults, particularly those who were missed during childhood because their presentation didn't match the historically male-skewed diagnostic criteria, make up a significant portion of the audience. Parents who recognize traits in themselves after a child's diagnosis are another common case. Healthcare professionals exploring their own neurodivergent traits use it as well.
The platform is not appropriate for children under 16, for individuals in acute psychiatric crisis, or for anyone who needs official documentation for legal, educational, or employment purposes. Those situations require in-person clinical evaluation.
The typical path starts with a single assessment — most users begin with the RAADS-R, which the platform surfaces as the default entry point. From there, users can add the AQ or CAT-Q to build a more complete picture. Assessments can be paused and resumed, and the platform recommends completing them in a quiet, unhurried environment to reduce the effect of situational stress on responses.
Once results are available, the platform encourages users to document specific real-life examples that align with their scores, then bring both the report and those examples to a licensed psychologist or psychiatrist for formal evaluation. It positions itself explicitly as a preparation tool, not a replacement for clinical judgment.
For users whose scores suggest significant autistic traits, MindSpectrum notes that formal diagnostic evaluation typically involves waitlists of six to eighteen months and costs ranging from $1,500 to $5,000 or more in the United States. Having a structured screening report can help users make the case for referral and arrive at appointments with useful documentation already prepared.
All assessment data is classified as Protected Health Information under HIPAA. Data is encrypted with AES-256 at rest and TLS 1.3 in transit, and the platform undergoes annual third-party compliance audits. MindSpectrum states it does not sell or share identifiable health data with insurers, employers, or advertisers. Users can download, correct, or permanently delete their data at any time.
The platform also supports GDPR and CCPA compliance and is available in 12 languages with culturally adapted score interpretations.
MindSpectrum operates on a freemium model. The core assessments are free to access, which removes the financial barrier that often delays people from exploring a potential autism diagnosis. Paid tiers — detailed under the Spectra plan — appear to offer additional features, though the free tier is sufficient for completing all three screening instruments and receiving results.
80-item clinically validated instrument with 97% sensitivity and 95% specificity, developed by Dr. Riva Ariella Ritvo and cited in 500+ research publications.
50-question tool developed at Cambridge University's Autism Research Centre, validated in 3,000+ studies across 20+ language translations.
25-question instrument measuring social masking and camouflaging strategies, with internal consistency exceeding α = 0.90.
AES-256 encryption at rest, TLS 1.3 in transit, MFA, and annual third-party audits. PHI never sold or shared with insurers, employers, or advertisers.
Score breakdowns by domain with scientific references, designed to support conversations with clinicians during formal evaluation.
定价模式
支持的平台
支持的语言
Available in 12 languages with culturally sensitive score interpretations, removing geographic and language barriers to screening.